Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse.
作者信息
Boddu P, Jorgensen J, Kantarjian H, Borthakur G, Kadia T, Daver N, Alvarado Y, Pemmaraju N, Bose P, Naqvi K, Yilmaz M, Pierce S, Brandt M, DiNardo C D, Jabbour E J, Konopleva M, Garcia-Manero G, Cortes J, Ravandi F
机构信息
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Leukemia. 2018 Jan;32(1):241-244. doi: 10.1038/leu.2017.285. Epub 2017 Sep 18.
PMID:28919634
Abstract
摘要
Zotero 插件